empty
 
 
hu
Keresés
Támogatás
Azonnali számlanyitás
Trading Platform
Befizetés/pénzfelvétel
Keresés
Kezdőknek Kereskedőknek Partnereknek Tartson egy kis szünetet Az InstaForexrol
hu
For Traders
Charts
#BMY

#BMY (Bristol-Myers Squibb Company). Exchange rate and online charts.

#BIIB Return to the list of instruments #BNTX

Currency converter

Bristol-Myers Squibb Company
58.48 USD
26 Nov 2024 17:19
Price Change (% chg)
$0
(0%)
Prev Close
Prev Close

Closing price, the previous day.
$58.75
Open
Open

Opening price.
$58.83
Day's High
Day's High

The highest price over the last trading day.
$59.04
Day's Low
Day's Low

The lowest price over the last trading day
$58.29
Week High
Week High

Price range high in the last week
$59.04
Week Low
Week Low

Price range low in the last week
$56.06
Download archive
Buy
58.48
Sell
58.48
Open the chart in full screen view
Buy
58.48
Sell
58.48
Download archive
Open the chart in full screen view

Bristol-Myers Squibb Co. About company

Bristol-Myers Squibb Co. is an international biopharmaceutical company established more than 100 years ago, in 1887. Initially, the company produced cough medicines, laxatives, and toothpaste.

Nowadays, the company specializes in the production of medicines for the treatment of cancer, HIV, as well as other serious diseases.

In 2019, the firm was absorbed by the Celgene company, which became one of the largest deals in the field at a total sum of $74 billion.

At the moment, the market cap of Bristol-Myers Squibb Co. totals $151.8 billion. The company’s revenue for 2021 came at $46.39 billion, whereas the net profit was $6.994 billion.

Shares of Bristol-Myers Squibb Co. and factors influencing them

The company’s stocks are traded on the New York Stock Exchange under the ticker of BMY.

Currently, shares of Bristol-Myers Squibb Co. are hovering within the range of $69-$71. During the year, the share price has been changing from $53 to $81.

When trading this asset, pay attention to the following factors:

  • Bristol-Myers Squibb Co. mainly cooperates with large wholesale companies and distributors and not directly with medical institutions, pharmacies, etc;
  • Research and new developments play a key role, but it takes a lot of time, on average about 14 years, and requires considerable spending;
  • The company has joint ventures and projects with other firms in this field;
  • The company's competitive advantages are features of its products, the effectiveness of marketing, and research work on new products.

Can't speak right now?
Ask your question in the chat.